Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia
HOCHHAUS, A ; O'BRIEN, S. G ; MONE, M ; GATHMANN, I ; HUGHES, T. P ; LARSON, R. A ; GUILHOT, F ; DRUKER, B. J ; BRANFORD, S ; FORONI, L ; GOLDMAN, J. M ; MÜLLER, M. C ; RADICH, J. P ; RUDOLTZ, M
Leukemia, 2009-06, Vol.23 (6), p.1054-1061 [Periódico revisado por pares]Avenel, NJ: Nature Publishing Group
Texto completo disponível